Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms
- 1 December 2003
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 64 (6) , 2238-2243
- https://doi.org/10.1046/j.1523-1755.2003.00310.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patientsNephrology Dialysis Transplantation, 2003
- Ademex: How Should it Change our Practice?Peritoneal Dialysis International, 2002
- The Negative Results of the Ademex Study may be Positive for Peritoneal Dialysis. Time for a Paradigm Shift in the Focus of Peritoneal Dialysis Adequacy?Peritoneal Dialysis International, 2002
- Beyond Canusa, DOQI, Ademex: What's Next?Peritoneal Dialysis International, 2002
- The ADEMEX StudyJournal of the American Society of Nephrology, 2002
- Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal DialysisJournal of the American Society of Nephrology, 2002
- Uremic Toxicity: Present State of the ArtThe International Journal of Artificial Organs, 2001
- Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of DialysisJournal of the American Society of Nephrology, 2001
- Effect of fluid and sodium removal on mortality in peritoneal dialysis patientsKidney International, 2001
- Adequacy of dialysis and nutrition in continuous peritoneal dialysisJournal of the American Society of Nephrology, 1996